Lorenzo Cosmi
Overview
Explore the profile of Lorenzo Cosmi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
128
Citations
7109
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vivarelli E, Perlato M, Accinno M, Brugnoli B, Milanese M, Cataudella E, et al.
Respiration
. 2025 Mar;
:1-15.
PMID: 40064152
Introduction: Asthma is a heterogeneous chronic inflammatory disease involving different underling pathogenetic mechanisms. We aimed to investigate the characteristics of patients with the diagnosis of asthma and primary antibody immunodeficiency...
2.
Bacherini D, Maggi L, Faraldi F, Sodi A, Vannozzi L, Mazzoni A, et al.
Int J Mol Sci
. 2024 Dec;
25(23).
PMID: 39684872
Recently, evidence has supported a significant role for immune and oxidative-mediated damage underlying the pathogenesis of different types of retinal diseases, including retinitis pigmentosa (RP). Our study aimed to evaluate...
3.
Di Santo A, Accinno M, Errante F, Capone M, Vultaggio A, Simoncini E, et al.
Clin Biochem
. 2024 Nov;
133-134:110838.
PMID: 39489392
Objectives: Monitoring of therapeutic antibody adalimumab (ADL) and of anti-adalimumab antibodies (AAA) in autoimmune diseases patients' sera has achieved increased attention since several studies showed a correlation between AAA levels...
4.
Caminati M, Brussino L, Carlucci M, Carlucci P, Carpagnano L, Caruso C, et al.
Cells
. 2024 Jul;
13(14.
PMID: 39056762
Hypereosinophilic syndrome (HES) encompasses a heterogeneous and complex group of different subtypes within the wider group of hypereosinophilic disorders. Despite increasing research interest, several unmet needs in terms of disease...
5.
Capone M, Vanni A, Salvati L, Lamacchia G, Mazzoni A, Maggi L, et al.
Immunol Lett
. 2024 Jun;
268:106886.
PMID: 38906482
Objective: Novel mRNA-based vaccines have been proven to be powerful tools in combating the global pandemic caused by SARS-CoV-2 protecting individuals, especially the immunocompromised, from COVID-19. Still, it remains largely...
6.
Bagnasco D, Brussino L, Biagini C, Cosmi L, De Corso E, La Mantia I, et al.
World Allergy Organ J
. 2024 Apr;
17(4):100895.
PMID: 38590723
No abstract available.
7.
Brugnoli B, Salvati L, Di Lauria N, Botta A, Tozzetti C, Biscarini A, et al.
Eur J Clin Microbiol Infect Dis
. 2024 Feb;
43(5):1003-1007.
PMID: 38379052
Infections that are unusually severe or caused by opportunistic pathogens are a hallmark of primary immunodeficiency (PID). Anti-cytokine autoantibodies (ACA) are an emerging cause of acquired immunodeficiency mimicking PID. Nocardia...
8.
Vanni A, Salvati L, Mazzoni A, Lamacchia G, Capone M, Francalanci S, et al.
Front Immunol
. 2023 Dec;
14:1322594.
PMID: 38106404
Background: Patients with B-cell lymphoma are a fragile category of subjects, particularly exposed to infections and characterized by an impaired vaccination response due to the disease itself and, even more,...
9.
Vultaggio A, Accinno M, Vivarelli E, Mecheri V, Maggiore G, Cosmi L, et al.
Allergy
. 2023 Oct;
78(12):3154-3165.
PMID: 37792721
Background: Eosinophils have been divided into different subpopulations with distinct phenotypes based on CD62L expression. No data are available regarding the correlation between eosinophils subphenotypes and clinical severity of asthma,...
10.
Cecchi L, Poncet P, Maltagliati L, Carli G, Macchia D, Maggi L, et al.
Ann Allergy Asthma Immunol
. 2023 Sep;
132(1):82-90.e1.
PMID: 37758056
Background: Pru p 7 was the first gibberellin-regulated protein (GRP) to be identified as a food allergen as the basis of a pollen food allergy syndrome. Objective: To clinically and...